Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Sep 15, 2021
- Accession no.
- 0001447362-21-000221
- Filed
- Sep 15, 2021
- Trade date
- Sep 14, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $247.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 | Common Stock | SSaleDisposed | −781 | $73.36F2 | −$57,294.16 | 161,852 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −472 | $74.65F5 | −$35,234.8 | 161,380 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −227 | $75.69F6 | −$17,181.63 | 161,153 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −186 | $76.43F7 | −$14,215.98 | 160,967 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −781 | $73.36F2 | −$57,294.16 | 149,251 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −473 | $74.65F5 | −$35,309.45 | 148,778 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −227 | $75.69F6 | −$17,181.63 | 148,551 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −186 | $76.43F7 | −$14,215.98 | 148,365 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $73.050 to $73.940, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $74.100 to $75.070, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $75.105 to $76.070, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $76.300 to $76.630, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.